Last Updated: August 2, 2026

NITROMIST Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nitromist patents expire, and what generic alternatives are available?

Nitromist is a drug marketed by Evus and is included in one NDA.

The generic ingredient in NITROMIST is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nitromist

A generic version of NITROMIST was approved as nitroglycerin by AM REGENT on May 24th, 1988.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for NITROMIST?
  • What are the global sales for NITROMIST?
  • What is Average Wholesale Price for NITROMIST?
Summary for NITROMIST
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for NITROMIST

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Evus NITROMIST nitroglycerin AEROSOL, METERED;SUBLINGUAL 021780-001 Nov 2, 2006 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for NITROMIST

See the table below for patents covering NITROMIST around the world.

Country Patent Number Title Estimated Expiration
Austria 237322 ⤷  Start Trial
Australia 1969397 ⤷  Start Trial
Canada 2251564 PULVERISATEUR BUCCAL NON POLAIRE POUR NITROGLYCERINE (BUCCAL, NON-POLAR SPRAY FOR NITROGLYCERIN) ⤷  Start Trial
Germany 69721020 ⤷  Start Trial
Denmark 0927032 ⤷  Start Trial
European Patent Office 0927032 PULVERISATEUR BUCCAL NON POLAIRE POUR NITROGLYCERINE (BUCCAL, NON-POLAR SPRAY FOR NITROGLYCERIN) ⤷  Start Trial
Spain 2197990 ⤷  Start Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.